Increased food intake with oxyntomodulin analogues

Por Price, Samantha L., Minnion, James S., Bloom, Stephen R.
Publicado no Peptides (2015)

Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats

Por Price, Samantha L., Minnion, James S., Bloom, Stephen R.
Publicado no Curr Ther Res Clin Exp (2015)

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

Por Akalestou, Elina, Christakis, Ioannis, Solomou, Antonia M., Minnion, James S., Rutter, Guy A., Bloom, Stephen R.
Publicado no Pancreas (2016)

Degradation Paradigm of the Gut Hormone, Pancreatic Polypeptide, by Hepatic and Renal Peptidases

Por Cuenco, Joyceline, Minnion, James, Tan, Tricia, Scott, Rebecca, Germain, Natacha, Ling, Yiin, Chen, Rong, Ghatei, Mohammad, Bloom, Stephen
Publicado no Endocrinology (2017)

The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers

Por Tan, Tricia, Behary, Preeshila, Tharakan, George, Minnion, James, Al-Najim, Werd, Albrechtsen, Nicolai J. Wewer, Holst, Jens J., Bloom, Stephen R.
Publicado no J Clin Endocrinol Metab (2017)

Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420

Por Tan, Tricia M, Field, Benjamin C T, Minnion, James S, Cuenco-Shillito, Joyceline, Chambers, Edward S, Zac-Varghese, Sagen, Brindley, Charlie J, Mt-Isa, Shahrul, Fiorentino, Francesca, Ashby, Deborah, Ward, Ian, Ghatei, Mohammad A, Bloom, Stephen R
Publicado em 2012

Combination of Peptide YY(3–36) with GLP-1(7–36 amide) Causes an Increase in First-Phase Insulin Secretion after IV Glucose

Por Tan, Tricia M., Salem, Victoria, Troke, Rachel C., Alsafi, Ali, Field, Benjamin C. T., De Silva, Akila, Misra, Shivani, Baynes, Kevin C. R., Donaldson, Mandy, Minnion, James, Ghatei, Mohammad A., Godsland, Ian F., Bloom, Stephen R.
Publicado no J Clin Endocrinol Metab (2014)